AI-ACCELERATED DRUG DISCOVERY

Target modalities

We specialize in developing novel modalities that are designed to address the limitations of traditional treatments. Leveraging cutting-edge AI technologies we created advanced workflows tailored for each therapeutic strategy, accelerating the discovery and optimization of novel therapeutic candidates.

Monospecific

We design monospecific small molecules and peptides for any protein target and indication:

Designing specifically for functional activity or binding affinity
Orthosteric, allosteric or cryptic binding pockets
Selectivity against up to 100 explicit off-targets
Discriminating between agonists and antagonists
See Monospecific workflow

Bispecific

Wide range of bispecific compounds could be designed with the warheads targeting any target protein:

Protein degraders (PROTACs and LYTACs)
Protein stabilizers (DUBTACs)
Protein cross-linkers and proximity engagers
Membrane protein internalization enhancers
See bispecific workflow

Bispecific

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Protein degraders (PROTACs and LYTACs)
Protein stabilizers (DUBTACs)
Protein cross-linkers and proximity engagers
Membrane protein internalization enhancers
See bispecific workflow

PPI modulators

Our technologies allows modulating protein-protein interactions in different ways even in the most challenging cases:

Identification of partner proteins
Predicting interaction interfaces and hot spots
Dedicated workflows for PPI disruptors and molecular glues
Efficient peptide to small molecule workflow
See PPI modulators workflow

Antibody mimetics

We provide a workflow for designing peptides and small molecule functional mimetics of antibodies with superior ADMET properties and oral administration:

Computational prediction of unknown epitopes
Design of small molecules functionally equivalents to antibody paratopes
Targeting alternative binding sites with antibody-mimicking effect
Optimization towards oral administration and membrane permeability
See antibody mimetics workflow

Antibody mimetics

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Computational prediction of unknown epitopes
Design of small molecules functionally equivalents to antibody paratopes
Targeting alternative binding sites with antibody-mimicking effect
Optimization towards oral administration and membrane permeability
See antibody mimetics workflow
Contact Us for more details
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.